Marinomed Biotech’s €5.4 Million Investment Agreement With Nice&Green

Herbst Kinsky advised Marinomed Biotech, while Schoenherr advised Nice & Green on the deal.Marinomed Biotech AG (VSE:MARI), an Austrian science-based biotech company with globally marketed therapeutics…

This content is for Standard 1 Year members only.
Login Join Now
Federica Tiefenthaler

Author: Federica Tiefenthaler

This content is for Standard 1 Year members only.
Login Join Now